-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

Benzinga·02/14/2025 18:01:35
Listen to the news
HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.